CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 1
Non-Antibody Products
Page 1,064 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide | A homolog of LOEA, characterized by the addition of an (R)-α-methyl… | 10 mg | 9001233-10 | More Info |
| (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide | A homolog of LOEA, characterized by the addition of an (R)-α-methyl… | 5 mg | 9001233-5 | More Info |
| 15(R)-Lipoxin A4 | An aspirin-triggered lipoxin that inhibits LTB4-induced chemotaxis, adhere… | 100 µg | 90415-100 | More Info |
| 15(R)-Lipoxin A4 | An aspirin-triggered lipoxin that inhibits LTB4-induced chemotaxis, adhere… | 25 µg | 90415-25 | More Info |
| 15(R)-Lipoxin A4 | An aspirin-triggered lipoxin that inhibits LTB4-induced chemotaxis, adhere… | 250 µg | 90415-250 | More Info |
| 15(R)-Lipoxin A4 | An aspirin-triggered lipoxin that inhibits LTB4-induced chemotaxis, adhere… | 50 µg | 90415-50 | More Info |
| (R)-Lisofylline | A potent inhibitor of the generation of phosphatidic acid (IC50 = 0.6 &mic… | 1 mg | 13616-1 | More Info |
| (R)-Lisofylline | A potent inhibitor of the generation of phosphatidic acid (IC50 = 0.6 &mic… | 10 mg | 13616-10 | More Info |
| (R)-Lisofylline | A potent inhibitor of the generation of phosphatidic acid (IC50 = 0.6 &mic… | 5 mg | 13616-5 | More Info |
| RM 133-3 | An ionizable cationic lipid; has been used in the formation of LNPs for th… | 10 mg | 38917-10 | More Info |
| RM 133-3 | An ionizable cationic lipid; has been used in the formation of LNPs for th… | 25 mg | 38917-25 | More Info |
| RM 133-3 | An ionizable cationic lipid; has been used in the formation of LNPs for th… | 5 mg | 38917-5 | More Info |
| RM 137-15 | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 10 mg | 38918-10 | More Info |
| RM 137-15 | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 25 mg | 38918-25 | More Info |
| RM 137-15 | An ionizable cationic lipid; has been used in the formation of LNPs; LNPs… | 5 mg | 38918-5 | More Info |
| R-(-)-Mandelic Acid | A synthetic intermediate useful for pharmaceutical synthesis. | 100 g | 10007128-100 | More Info |
| R-(-)-Mandelic Acid | A synthetic intermediate useful for pharmaceutical synthesis. | 25 g | 10007128-25 | More Info |
| R-(-)-Mandelic Acid | A synthetic intermediate useful for pharmaceutical synthesis. | 250 g | 10007128-250 | More Info |
| R-(-)-Mandelic Acid | A synthetic intermediate useful for pharmaceutical synthesis. | 50 g | 10007128-50 | More Info |
| RMC-4550 | A SHP-2 inhibitor (IC50 = 1.55 nM); selective for SHP-2 over a panel of 14… | 1 mg | 31011-1 | More Info |
| RMC-4550 | A SHP-2 inhibitor (IC50 = 1.55 nM); selective for SHP-2 over a panel of 14… | 10 mg | 31011-10 | More Info |
| RMC-4550 | A SHP-2 inhibitor (IC50 = 1.55 nM); selective for SHP-2 over a panel of 14… | 25 mg | 31011-25 | More Info |
| RMC-4550 | A SHP-2 inhibitor (IC50 = 1.55 nM); selective for SHP-2 over a panel of 14… | 5 mg | 31011-5 | More Info |
| RMC-4630 | A SHP-2 inhibitor | 1 mg | 38772-1 | More Info |
| RMC-4630 | A SHP-2 inhibitor | 10 mg | 38772-10 | More Info |
| RMC-4630 | A SHP-2 inhibitor | 5 mg | 38772-5 | More Info |
| RMC-4630 | A SHP-2 inhibitor | 500 µg | 38772-500 | More Info |
| (R)-(-)-Mellein | A dihydroisocoumarin compound with a variety of biological activities incl… | 10 mg | 10311-10 | More Info |
| (R)-(-)-Mellein | A dihydroisocoumarin compound with a variety of biological activities incl… | 100 mg | 10311-100 | More Info |
| (R)-(-)-Mellein | A dihydroisocoumarin compound with a variety of biological activities incl… | 5 mg | 10311-5 | More Info |
| (R)-(-)-Mellein | A dihydroisocoumarin compound with a variety of biological activities incl… | 50 mg | 10311-50 | More Info |
| (R)-Mephenytoin | The (R) enantiomer of mephenytoin; can be demethylated by CYP2C9 to form t… | 1 mg | 25891-1 | More Info |
| (R)-Mephenytoin | The (R) enantiomer of mephenytoin; can be demethylated by CYP2C9 to form t… | 10 mg | 25891-10 | More Info |
| (R)-Mephenytoin | The (R) enantiomer of mephenytoin; can be demethylated by CYP2C9 to form t… | 25 mg | 25891-25 | More Info |
| (R)-Mephenytoin | The (R) enantiomer of mephenytoin; can be demethylated by CYP2C9 to form t… | 5 mg | 25891-5 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 10 mg | 90070-10 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 25 mg | 90070-25 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 5 mg | 90070-5 | More Info |
| R-1 Methanandamide | A potent CB1 receptor agonist in the methanandamide series; selective for… | 50 mg | 90070-50 | More Info |
| R-2 Methanandamide | A CB analog with a methyl group in the (R) configuration at C-2 of the eth… | 10 mg | 90074-10 | More Info |
| R-2 Methanandamide | A CB analog with a methyl group in the (R) configuration at C-2 of the eth… | 25 mg | 90074-25 | More Info |
| R-2 Methanandamide | A CB analog with a methyl group in the (R) configuration at C-2 of the eth… | 5 mg | 90074-5 | More Info |
| R-1 Methanandamide Phosphate | A water soluble prodrug analog of AEA; similar activity to AEA in the grow… | 1 mg | 10004281-1 | More Info |
| R-1 Methanandamide Phosphate | A water soluble prodrug analog of AEA; similar activity to AEA in the grow… | 10 mg | 10004281-10 | More Info |
| R-1 Methanandamide Phosphate | A water soluble prodrug analog of AEA; similar activity to AEA in the grow… | 5 mg | 10004281-5 | More Info |
| 15(R)-15-methyl Prostaglandin A2 | A potential impurity in the production of commercial lots of bulk arbapros… | 1 mg | 10270-1 | More Info |
| 15(R)-15-methyl Prostaglandin A2 | A potential impurity in the production of commercial lots of bulk arbapros… | 10 mg | 10270-10 | More Info |
| 15(R)-15-methyl Prostaglandin A2 | A potential impurity in the production of commercial lots of bulk arbapros… | 5 mg | 10270-5 | More Info |
| 15(R)-15-methyl Prostaglandin D2 | The physiological actions of PGD2 include regulation of sleep, lowering of… | 1 mg | 12720-1 | More Info |
| 15(R)-15-methyl Prostaglandin D2 | The physiological actions of PGD2 include regulation of sleep, lowering of… | 500 µg | 12720-500 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile